Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Drug-Induced Liver Injury Associated With Antidepressive Psychopharmacotherapy: An Explorative Assessment Based on Quantitative Signal Detection Using Different MedDRA Terms.

Gahr M, Zeiss R, Lang D, Connemann BJ, Hiemke C, Schönfeldt-Lecuona C.

J Clin Pharmacol. 2016 Jun;56(6):769-78. doi: 10.1002/jcph.662. Epub 2015 Dec 14.

PMID:
26470856
2.

Medication management of irritable bowel syndrome.

Trinkley KE, Nahata MC.

Digestion. 2014;89(4):253-67. doi: 10.1159/000362405. Epub 2014 Jul 2. Review.

3.

Perazine for schizophrenia.

Leucht S, Helfer B, Hartung B.

Cochrane Database Syst Rev. 2014 Jan 15;(1):CD002832. doi: 10.1002/14651858.CD002832.pub3. Review.

PMID:
24425538
4.

Clinical Pharmacogenetics Implementation Consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants.

Hicks JK, Swen JJ, Thorn CF, Sangkuhl K, Kharasch ED, Ellingrod VL, Skaar TC, Müller DJ, Gaedigk A, Stingl JC; Clinical Pharmacogenetics Implementation Consortium.

Clin Pharmacol Ther. 2013 May;93(5):402-8. doi: 10.1038/clpt.2013.2. Epub 2013 Jan 16. Review.

5.

Histamine-1 receptor antagonism for treatment of insomnia.

Vande Griend JP, Anderson SL.

J Am Pharm Assoc (2003). 2012;52(6):e210-9. doi: 10.1331/JAPhA.2012.12051. Review.

PMID:
23229983
6.

Antidepressants for patients with tinnitus.

Baldo P, Doree C, Molin P, McFerran D, Cecco S.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD003853. doi: 10.1002/14651858.CD003853.pub3. Review.

PMID:
22972065
7.

Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.

Tedeschini E, Levkovitz Y, Iovieno N, Ameral VE, Nelson JC, Papakostas GI.

J Clin Psychiatry. 2011 Dec;72(12):1660-8. doi: 10.4088/JCP.10r06531.

PMID:
22244025
8.

FPIN's clinical inquiries: Antidepressants for the treatment of insomnia in patients with depression.

Clark MS, Smith PO, Jamieson B.

Am Fam Physician. 2011 Nov 1;84(9):1-2. No abstract available.

9.

Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials.

Levkovitz Y, Tedeschini E, Papakostas GI.

J Clin Psychiatry. 2011 Apr;72(4):509-14. doi: 10.4088/JCP.09m05949blu.

PMID:
21527126
10.

Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis.

Rahimi R, Nikfar S, Rezaie A, Abdollahi M.

World J Gastroenterol. 2009 Apr 7;15(13):1548-53.

11.

Tricyclic antidepressant poisoning: an evidence-based consensus guideline for out-of-hospital management.

Woolf AD, Erdman AR, Nelson LS, Caravati EM, Cobaugh DJ, Booze LL, Wax PM, Manoguerra AS, Scharman EJ, Olson KR, Chyka PA, Christianson G, Troutman WG.

Clin Toxicol (Phila). 2007;45(3):203-33.

PMID:
17453872
12.

Perazine for schizophrenia.

Leucht S, Hartung B.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD002832. Review. Update in: Cochrane Database Syst Rev. 2014;1:CD002832.

PMID:
16625562
13.

Antidepressants and their effect on sleep.

Mayers AG, Baldwin DS.

Hum Psychopharmacol. 2005 Dec;20(8):533-59. Review.

PMID:
16229049
14.

Risk of fetal exposure to tricyclic antidepressants.

Wen SW, Walker M.

J Obstet Gynaecol Can. 2004 Oct;26(10):887-92. English, French.

PMID:
15507199
15.

Perazine for schizophrenia.

Leucht S, Hartung B.

Cochrane Database Syst Rev. 2002;(1):CD002832. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD002832.

PMID:
11869638
16.

Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis.

Jackson JL, O'Malley PG, Tomkins G, Balden E, Santoro J, Kroenke K.

Am J Med. 2000 Jan;108(1):65-72.

PMID:
11059442
17.

Supplemental Content

Loading ...
Support Center